The invention relates to a galanthamine analogue capable of inhibiting
cholinesterase activity and a preparation method and application of the galanthamine analogue, the structural general formula of the galanthamine analogue is shown as a formula (IA), a formula (IB) or a formula (IC), in the formula (IA), R1 is selected from
hydrogen, o-
fluorine, m-
fluorine, p-
fluorine, 2, 4-difluorine, m-
trifluoromethyl, p-methyl, 3, 5-dimethoxy, p-
chlorine, p-nitro, p-cyano or p-trifluoromethoxy, and R2 is selected from
hydrogen, o-fluorine, m-fluorine, p-fluorine, 2, 4-difluoro, m-
trifluoromethyl, p-methyl, 3, 5-dimethoxy, p-
chlorine, p-nitro, p-cyano or p-trifluoromethoxy; in the formula (IB), R2 is selected from phenyl, o-fluorophenyl, m-fluorophenyl, p-fluorophenyl, 2, 4-difluorophenyl, 3, 5-difluorophenyl, o-methylphenyl, p-methylphenyl, p-methoxyphenyl, indole, p-cyanophenyl, p-trifluoromethylphenyl, p-trifluoromethoxyphenyl, p-nitrophenyl or
naphthalene ring; in the formula (IC), R3 is selected from
hydrogen, o-fluorine, m-fluorine, p-fluorine, m-
chlorine, p-chlorine, p-methyl, o-methoxyl, m-methoxyl or p-methoxyl. The inhibition activity of the galanthamine analogue on
cholinesterase is superior to that of galanthamine, and the galanthamine analogue is expected to be used for treating
cholinergic function disorder related diseases; # imgabs0 #